High Vectra DA scores identified patients with early RA at higher risk of joint damage, while low to moderate scores identified a lower risk. Early RA patients with high Vectra DA scores at baseline were seven times as likely to have rapid radiographic progression (Δ SHS >5) over one year as those with low or moderate Vectra DA scores.¹
Only one patient (1/34) with a low or moderate Vectra DA score at baseline experienced radiographic progression (Δ SHS >5) over 1 year.¹
SHS = Van der Heijde-modified Sharp Score
*The P value 0.008 represents low/moderate vs high Vectra DA score. The P value for moderate vs high Vectra DA score is 0.021.¹
Vectra DA better discriminated the risk for radiographic progression compared with CRP, ESR and DAS28-ESR.¹
SHS = Van der Heijde-modified Sharp Score
Patients who lowered their Vectra DA scores from baseline to Year 1 were less likely to experience rapid radiographic progression from Year 1 to Year 2 than those whose Vectra DA scores remained high.†